Comparison of Doxorubicin and Cyclophosphamide Versus Single-Agent Paclitaxel As Adjuvant Therapy for Breast Cancer in Women With 0 to 3 Positive Axillary Nodes: CALGB 40101 (Alliance) Shulman LN, Berry DA, Cirrincione CT, et al (Dana-Farber Cancer Inst, Boston, MA; MD Anderson Cancer Ctr, Houston, TX; Duke Univ Med Ctr, Durham, NC; et al) J Clin Oncol 32:2311-2317, 2014§

Publication date: 2015 Source:Breast Diseases: A Year Book Quarterly, Volume 26, Issue 1 Author(s): J.Y. Shih , L.J. Goldstein
Source: Breast Diseases: A Year Book Quarterly - Category: Cancer & Oncology Source Type: research